A detailed history of 1 St Source Bank transactions in Amgen Inc stock. As of the latest transaction made, 1 St Source Bank holds 2,913 shares of AMGN stock, worth $920,508. This represents 0.05% of its overall portfolio holdings.

Number of Shares
2,913
Previous 2,912 0.03%
Holding current value
$920,508
Previous $827,000 10.04%
% of portfolio
0.05%
Previous 0.05%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$262.75 - $319.31 $262 - $319
1 Added 0.03%
2,913 $910,000
Q1 2024

May 09, 2024

SELL
$268.87 - $324.56 $7,797 - $9,412
-29 Reduced 0.99%
2,912 $827,000
Q4 2023

Feb 08, 2024

SELL
$255.7 - $288.46 $59,066 - $66,634
-231 Reduced 7.28%
2,941 $847,000
Q3 2023

Nov 09, 2023

SELL
$218.65 - $271.46 $52,913 - $65,693
-242 Reduced 7.09%
3,172 $852,000
Q2 2023

Aug 09, 2023

SELL
$214.27 - $253.37 $15,641 - $18,496
-73 Reduced 2.09%
3,414 $757,000
Q1 2023

May 09, 2023

SELL
$225.79 - $275.2 $1,128 - $1,376
-5 Reduced 0.14%
3,487 $842,000
Q4 2022

Feb 13, 2023

SELL
$229.03 - $291.01 $21,070 - $26,772
-92 Reduced 2.57%
3,492 $917,000
Q3 2022

Nov 04, 2022

BUY
$224.46 - $253.15 $44,443 - $50,123
198 Added 5.85%
3,584 $808,000
Q2 2022

Aug 05, 2022

SELL
$230.71 - $256.74 $38,759 - $43,132
-168 Reduced 4.73%
3,386 $824,000
Q1 2022

May 05, 2022

BUY
$219.27 - $242.57 $20,830 - $23,044
95 Added 2.75%
3,554 $859,000
Q4 2021

Feb 09, 2022

SELL
$198.88 - $227.6 $1,591 - $1,820
-8 Reduced 0.23%
3,459 $778,000
Q3 2021

Nov 05, 2021

BUY
$212.27 - $248.7 $424 - $497
2 Added 0.06%
3,467 $737,000
Q2 2021

Aug 03, 2021

BUY
$233.58 - $259.14 $35,737 - $39,648
153 Added 4.62%
3,465 $845,000
Q1 2021

May 07, 2021

SELL
$221.91 - $258.6 $19,084 - $22,239
-86 Reduced 2.53%
3,312 $824,000
Q4 2020

Feb 05, 2021

BUY
$216.38 - $257.67 $27,047 - $32,208
125 Added 3.82%
3,398 $781,000
Q3 2020

Oct 30, 2020

SELL
$234.65 - $260.95 $5,162 - $5,740
-22 Reduced 0.67%
3,273 $832,000
Q2 2020

Aug 07, 2020

BUY
$197.81 - $242.74 $35,210 - $43,207
178 Added 5.71%
3,295 $777,000
Q1 2020

Apr 29, 2020

SELL
$182.24 - $241.7 $57,770 - $76,618
-317 Reduced 9.23%
3,117 $632,000
Q4 2019

Jan 27, 2020

SELL
$189.21 - $243.2 $6,622 - $8,512
-35 Reduced 1.01%
3,434 $828,000
Q3 2019

Nov 06, 2019

SELL
$174.11 - $208.62 $30,817 - $36,925
-177 Reduced 4.85%
3,469 $671,000
Q2 2019

Jul 29, 2019

SELL
$166.7 - $195.41 $16,670 - $19,541
-100 Reduced 2.67%
3,646 $672,000
Q1 2019

Apr 29, 2019

BUY
$180.87 - $203.88 $112,501 - $126,813
622 Added 19.91%
3,746 $712,000
Q4 2018

Feb 11, 2019

BUY
$178.4 - $208.25 $20,337 - $23,740
114 Added 3.79%
3,124 $608,000
Q3 2018

Oct 31, 2018

BUY
$185.29 - $208.89 $6,485 - $7,311
35 Added 1.18%
3,010 $624,000
Q2 2018

Aug 02, 2018

SELL
$166.05 - $186.51 $70,405 - $79,080
-424 Reduced 12.47%
2,975 $549,000
Q1 2018

Apr 24, 2018

SELL
$169.43 - $198.0 $21,348 - $24,948
-126 Reduced 3.57%
3,399 $579,000
Q3 2017

Oct 27, 2017

BUY
$167.29 - $191.0 $589,697 - $673,275
3,525
3,525 $657,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track 1 St Source Bank Portfolio

Follow 1 St Source Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 1 St Source Bank, based on Form 13F filings with the SEC.

News

Stay updated on 1 St Source Bank with notifications on news.